Re: Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis

Affiliations

¹ Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: cigliola.antonio@hsr.it.
² Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
³ Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

Multicenter Study

Antonio Cigliola et al. Eur Urol. 2023 Dec.

. 2023 Dec;84(6):602-603.

doi: 10.1016/j.eururo.2023.06.026. Epub 2023 Jul 12.

¹ Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: cigliola.antonio@hsr.it.
² Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
³ Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

No abstract available

Comment on

Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta AR, Ballas LK, Niemierko A, Lajkosz K, Kuk C, Miranda G, Drumm M, Mari A, Thio E, Fleshner NE, Kulkarni GS, Jewett MAS, Bristow RG, Catton C, Berlin A, Sridhar SS, Schuckman A, Feldman AS, Wszolek M, Dahl DM, Lee RJ, Saylor PJ, Michaelson MD, Miyamoto DT, Zietman A, Shipley W, Chung P, Daneshmand S, Efstathiou JA. Zlotta AR, et al. Lancet Oncol. 2023 Jun;24(6):669-681. doi: 10.1016/S1470-2045(23)00170-5. Epub 2023 May 12. Lancet Oncol. 2023. PMID: 37187202